CV Sciences, Inc. Gross Profit

• CV Sciences, Inc. showed a decrease of -5.8% in Gross Profit from 2024 to 2025.
• This data is from CV Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2013: $91.4 thousand | Q3 2013: $115.1 thousand | Q1 2014: $1.61 million | Q2 2014: $1.80 million | Q3 2014: $1.12 million | Q1 2015: $1.58 million | Q2 2015: $1.29 million | Q3 2015: $2.46 million | Q1 2016: $1.63 million | Q2 2016: $1.66 million | Q3 2016: $1.89 million | Q1 2017: $2.43 million | Q2 2017: $2.84 million | Q3 2017: $4.00 million | Q1 2018: $5.56 million | Q2 2018: $9.06 million | Q3 2018: $9.95 million | Q1 2019: $10.56 million | Q2 2019: $11.95 million | Q3 2019: $8.43 million | Q1 2020: $4.01 million | Q2 2020: $2.32 million | Q3 2020: $2.46 million | Q1 2021: $2.36 million | Q2 2021: $2.29 million | Q3 2021: $2.36 million | Q1 2022: $1.16 million | Q2 2022: $1.27 million | Q3 2022: $1.56 million | Q1 2023: $1.78 million | Q2 2023: $1.72 million | Q3 2023: $1.84 million | Q1 2024: $1.85 million | Q2 2024: $1.86 million | Q3 2024: $1.78 million | Q1 2025: $1.66 million | Q2 2025: $1.84 million | Q3 2025: $1.58 million.
• Historical annual values: Fiscal year 2025: $6.75 million | Fiscal year 2024: $7.17 million | Fiscal year 2023: $7.09 million | Fiscal year 2022: $5.55 million | Fiscal year 2021: $8.62 million | Fiscal year 2020: $11.01 million | Fiscal year 2019: $35.09 million | Fiscal year 2018: $33.88 million | Fiscal year 2017: $14.49 million | Fiscal year 2016: $7.00 million | Fiscal year 2015: $6.73 million | Fiscal year 2014: $5.80 million | Fiscal year 2013: $1.27 million | Fiscal year 2012: $0.00.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026